Home
Scholarly Works
The Importance of Reporting Patient Recruitment...
Journal article

The Importance of Reporting Patient Recruitment Details in Phase III Trials

Authors

Wright JR; Bouma S; Dayes I; Sussman J; Simunovic MR; Levine MN; Whelan TJ

Journal

Journal of Clinical Oncology, Vol. 24, No. 6, pp. 843–845

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

February 20, 2006

DOI

10.1200/jco.2005.02.6005

ISSN

0732-183X

Associated Experts

Ian Stuart Dayes

Associate Professor, Oncology
Visit profile

James Wright

Associate Professor, Oncology
Visit profile

Jonathan Sussman

Professor, Oncology
Visit profile

Mark Norman Levine

Professor Emeritus, Oncology
Visit profile

Marko Simunovic

Professor, Surgery
Visit profile

Timothy Whelan

Professor, Oncology
Visit profile

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences3211 Oncology and carcinogenesis

Medical Subject Headings (MeSH)

Clinical Trials, Phase III as TopicHumansPatient SelectionResearch Design
View published work (Non-McMaster Users)
View published work (McMaster Users)

Contact the Experts team

Get technical help
or
Provide website feedback